Slørdahl KS, Puco K, Falk RS, Dyvik I, Brabrand S, Niehusmann P, Steinskog ESS, Blix ES, Flobak Å, Oppedal IA, Meltzer S, Torkildsen CF, Blakstad H, Lindemann K, Smeland S, Amundsen A, Taskén K, Helland Å, InPred Consortium(2026) Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial Acta Oncol, 65, 90-96 DOI 10.2340/1651-226X.2026.45086, PubMed 41664938
Negaard HFS, Haugnes HS, Fosså SD, Gjerset GM, Edvardsen E, Larsen KO, Tandstad T, Raastad T, Wisløff T, Thorsen L(2026) Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular Cancer Clin Genitourin Cancer, 102507(in press) DOI 10.1016/j.clgc.2026.102507, PubMed 41651700
Zilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier Cet al.(2026) Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial Eur Urol Oncol(in press) DOI 10.1016/j.euo.2026.01.001, PubMed 41565552
